James O. Lindsay

4 Newark Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 156 publications

Systemic reprogramming of monocytes in Crohn's disease promotes their intestinal inflammatory function.

Systemic reprogramming of monocytes in Crohn's disease promotes their intestinal inflammatory function.

Journal: JCI insight

Published: August 11, 2026

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: May 10, 2026

Defining Research Priorities in Nutrition and Inflammatory Bowel Disease: Insights From the Nutrition and IBD Research Group.

Defining Research Priorities in Nutrition and Inflammatory Bowel Disease: Insights From the Nutrition and IBD Research Group.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 12, 2026

IOIBD: the International Organization for the Study of Inflammatory Bowel Disease.

IOIBD: the International Organization for the Study of Inflammatory Bowel Disease.

Journal: Therapeutic advances in gastroenterology

Published: February 15, 2026

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Journal: Gut

Published: December 12, 2025

Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study.

Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study.

Journal: Journal of Crohn's & colitis

Published: December 04, 2025

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial.

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial.

Journal: BMJ open gastroenterology

Published: October 22, 2025

Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies.

Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 08, 2025

Effects of Stress, Vagal Nerve Stimulation and Disease Activity on Circulating Cytokines, Quantified by an Ultrasensitive Technique, in Ulcerative Colitis: A Pilot Study.

Effects of Stress, Vagal Nerve Stimulation and Disease Activity on Circulating Cytokines, Quantified by an Ultrasensitive Technique, in Ulcerative Colitis: A Pilot Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: May 29, 2025

Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn's disease in the UK (COMMODUS).

Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn's disease in the UK (COMMODUS).

Journal: Current medical research and opinion

Published: May 22, 2025

Tulisokibart shows promise for Crohn's disease.

Tulisokibart shows promise for Crohn's disease.

Journal: The lancet. Gastroenterology & hepatology

Published: March 24, 2025

Developing an adaptive platform trial for evaluation of medical treatments for Crohn's disease.

Developing an adaptive platform trial for evaluation of medical treatments for Crohn's disease.

Journal: Nature reviews. Gastroenterology & hepatology

Published: March 05, 2025

Showing 1-12 of 156

Last Updated: 09/26/2026